MEDICAL BIOLOGICAL WARFARE DEFNSIVE DOCTRINE FOR DS

File: 123096_sep96_decls38_0001.txt
Page: 0001
Total Pages: 2

Subject: MEDICAL BIOLOGICAL WARFARE DEFNSIVE DOCTRINE FOR DS             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: CAUTIONARY NOTE                                                                                 

Document Number:       1001

Folder Seq  #:         14



                                        UNCLASSIFIED
                                       0[7tlprT
                                             VL 1




                                                                   23 Dec 90

                  MEDICAL BIOLOGICAL WARFARE (BW) DEFENSIVE DOCTRINE
                              FOR OPERATION DESERT SHIELD

         1. The primary defensive measures against all forms of BW agents
         are individual protection and collective protection.

         2. The best pre-@osure protection is immunization. For
         Operation Desert Shield, those service members (SM) identified as
         "at risk" should be vaccinated with anthrax vaccine and botulinum
         toxoid.

         3. Antibiotics in conjunction with immunization (either primary or
         booster) or antitoxin provide protection against anthrax and
         against botulinum toxin, respectively, following exposure. These
         modalities are most effective prior to onset of clinical illness.

         4. Anthrax

             a. Pre-exposure vaccination - The anthrax vaccine (0.5 ml
         doses) is given at day 0, 14, and 28 with 3 additional doses given
         at six month intervals. For Operation Desert Shield the modified
         series is given at day 0 and 14. Significant levels of antibody
         and a protective level against anthrax can be expected two weeks
         after the second vaccination.

             b. Post-exposure treatment

                 (1) All SM will be issued a blister pack of ten
         Ciprofloxacin tablets (500 mg) with instructions to take one tablet
         every 12 hours. The decision to begin taking the antibiotic will
         be made by the tactical commander based on confirmation of exposure
         or high probability of exposure. The tactical commander will be
         advised by his Intelligence officer, Surgeon, and Chemical
         Officer. other indicators of a BW attack are warning from the few
 at selected sites and the NBC
         Reporting System.

                 (2) If an attack with anthrax has been confirmed, the SM
         must complete the vaccination series. In addition, Ciproflaxacin
         antibiotic treatment will continue for at least 30 days. If
         suspicious clinical symptoms occur, SM will be treated with oral
         Ciprofloxacin (1000 rag loading dose, then 750 mg twice daily) or
         intravenous doxycycline (200 mg loading dose, then 100 mg twice
         daily). (Parenteral Ciprofloxacin is not available at the present
         time.)
         DECLASSIFIED
         ON: 09 DEC 96
         BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958

                                           -r_ T
                                    O-Eti I X L I

                                  UNCLASSIFIED

Document 2 f:/Week-36/BX003201/CAUTIONARY NOTE/medical biological warfare defnsive doctrine for:12179609283439
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = CAUTIONARY NOTE
Folder Seq # = 14
Subject = MEDICAL BIOLOGICAL WARFARE DEFNSIVE DOCTRINE FOR
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996